Stockwinners is one of the oldest stock advisory services on the web. We believe that education and up-to-date information are the best tools available to today's investors. Knowledge is power! We provide upgrades downgrades, latest financial news, earnings report, real time option reports on our site.
Hewlett Packard Enterprise (HPE) and Cray (CRAY) announced that the companies have entered into a definitive agreement under which HPE will acquire Cray for $35.00 per share in cash, in a transaction valued at approximately $1.3B, net of cash.
Advanced Energy to acquire Artesyn Embedded Power for $400M Advanced Energy (AEIS) announced that it has entered into a definitive agreement to acquire the Embedded Power business of Artesyn Embedded Technologies from Platinum Equity. The total consideration for this transaction will be approximately $400M. Strategic benefits of the deal include: “Creates a premier global power …
Under the terms of the agreement, which was unanimously approved by Zayo's Board of Directors, shareholders will receive $35.00 in cash per share of Zayo's common stock in a transaction valued at $14.3 billion, including the assumption of $5.9 billion of Zayo's net debt obligations.
Park Hotels & Resorts (PK) and Chesapeake Lodging Trust (CHSP) announced that they have entered into a definitive merger agreement under which Park will acquire all the outstanding shares of Chesapeake in a cash and stock transaction valued at approximately $2.7B.
Concurrently with this offering of common stock and pursuant to a separate prospectus supplement, Tesla is offering convertible senior notes due 2024 to the public in an aggregate principal amount of $1.35B, or $1.55B if the underwriters for the concurrent convertible notes offering exercise in full their option to purchase additional notes.
NEJM reports ‘medical breakthrough’ in Mustang Bio cell and gene therapy Mustang Bio (MBIO) announced that the New England Journal of Medicine has published data from St. Jude Children’s Research Hospital, the nation’s “leading hospital” for understanding, treating and curing childhood cancer and other life-threatening diseases. The data comes from a Phase 1/2 clinical trial …